Detalhe da pesquisa
1.
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia.
Curr Issues Mol Biol
; 46(4): 2946-2960, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666914
2.
Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era.
Br J Haematol
; 204(2): 386-388, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984996
3.
Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL).
Br J Haematol
; 204(2): 389-390, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964473
4.
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood
; 139(15): 2347-2354, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108372
5.
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Hematol Oncol
; 42(1): e3241, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058031
6.
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Ann Hematol
; 103(5): 1587-1599, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194088
7.
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity After Supportive Stem Cell Boost in Multiple Myeloma.
Acta Haematol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447541
8.
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia.
Curr Issues Mol Biol
; 45(9): 7011-7026, 2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754227
9.
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779592
10.
Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.
BMC Cancer
; 23(1): 345, 2023 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061680
11.
Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma.
Hematol Oncol
; 41(5): 912-921, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452600
12.
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Br J Clin Pharmacol
; 89(7): 2304-2308, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37050863
13.
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.
Int J Mol Sci
; 24(6)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982764
14.
Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients.
J Infect Dis
; 225(8): 1482-1493, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415049
15.
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma.
Curr Issues Mol Biol
; 44(4): 1463-1471, 2022 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723356
16.
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Blood
; 136(3): 328-338, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321172
17.
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Blood
; 136(6): 698-714, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350520
18.
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era.
Hematol Oncol
; 40(2): 292-296, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817087
19.
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia.
Int J Mol Sci
; 23(20)2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293442
20.
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score).
J Stroke Cerebrovasc Dis
; 31(8): 106609, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753093